Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AMRI announced that it has completed the acquisition of Prime European Therapeuticals S.p.A., also known as "Euticals", a privately-held company headquartered in Lodi, Italy, specializing in custom synthesis and the manufacture of active ...
read more
AMRI announced the company’s manufacturing facility in Rensselaer, NY has been designated “Industry Leader” as part of its re-certification under the SafeBridge® program for "Potent Compound Safety Certification."
read more
Thursday, November 30, 2017
AMRI has more than doubled its current bulk API aseptic manufacturing capacity.
read more
AMRI will expand its nuclear magnetic resonance spectroscopy capabilities in Europe with the addition of the Bruker AVANCE NEO 600 MHz NMR Spectrometer.
read more
AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced today a key addition to the management team at its Singapore location. Saravanakumar Dhakshinamoorthy, Ph.D. joins AMRI’s Singapore site as Director of ...
read more
Thursday, January 21, 2016
AMRI has announced that Dawn M. Von Rohr, will join AMRI as Sr. Vice President, API, effective January 25, 2016. Ms. Von Rohr will report to George Svokos, Chief Operating Officer, and will be a member of the executive team led by President and Chief...
read more
Tuesday, January 12, 2021
AMRI announced its Albuquerque, New Mexico, facility has been approved for inclusion in the BARDA contract development and manufacturing organization network.
read more
AMRI has announced its ongoing commitment to do its part in support of public health needs amidst the COVID-19 pandemic.
read more
AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from April 2011 to March 2012. This is the second year in a row...
read more
AMRI announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine.
read more
AMRI will now offer its impurity solutions as a stand-alone service.
read more
Monday, December 07, 2015
Albany Molecular Research Inc. (AMRI) has launched its new U.S.-based integrated drug discovery center in Buffalo, N.Y. Located on the Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic ...
read more
Wednesday, August 24, 2016
AMRI has entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology and has completed several projects for its customers.
read more
AMRI has been named as the exclusive supplier of the API in Cassiopea SpA’s recently approved acne treatment, Winlevi cream 1%.
read more
Wednesday, January 10, 2018
AMRI announced Michael Mulhern has joined the company as chief executive officer, succeeding William S. Marth.
read more